Dendreon Corporation - DNDN- Profile

Dendreon Corporation. The Company's principal activities are to discover and develop novel products for the treatment of diseases through innovative manipulation of the immune system. It's product pipeline is focused on treatment of cancer and includes therapeutic vaccines, monoclonal antibodies, small molecules and pro-drugs. It's product Provenge, a therapeutic vaccine is used for the treatment of prostate cancer and APC8024 is used for the treatment of breast, ovarian and other solid tumors. It own worldwide commercialization rights for Provenge. It discovered the tumor antigen trp-p8 and it is presently working with Genentech Inc. to utilize this protein for drug development. It's manufacturing process incorporates two elements: the Antigen Delivery Cassette and antigen-presenting cells. It opeates in United States. Discovers and develops novel products for the treatment of diseases through innovative manipulation of the immune system